JP2021501201A5 - - Google Patents

Download PDF

Info

Publication number
JP2021501201A5
JP2021501201A5 JP2020543254A JP2020543254A JP2021501201A5 JP 2021501201 A5 JP2021501201 A5 JP 2021501201A5 JP 2020543254 A JP2020543254 A JP 2020543254A JP 2020543254 A JP2020543254 A JP 2020543254A JP 2021501201 A5 JP2021501201 A5 JP 2021501201A5
Authority
JP
Japan
Prior art keywords
peptide
polypeptide conjugate
staple
amino acid
conjugate according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020543254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021501201A (ja
JP7780253B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/057894 external-priority patent/WO2019084528A1/en
Publication of JP2021501201A publication Critical patent/JP2021501201A/ja
Publication of JP2021501201A5 publication Critical patent/JP2021501201A5/ja
Priority to JP2023115915A priority Critical patent/JP2023134675A/ja
Application granted granted Critical
Publication of JP7780253B2 publication Critical patent/JP7780253B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020543254A 2017-10-27 2018-10-28 ステープルペプチドの細胞内送達のためのポリペプチド接合体 Active JP7780253B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023115915A JP2023134675A (ja) 2017-10-27 2023-07-14 ステープルペプチドの細胞内送達のためのポリペプチド接合体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762578213P 2017-10-27 2017-10-27
US62/578,213 2017-10-27
PCT/US2018/057894 WO2019084528A1 (en) 2017-10-27 2018-10-28 POLYPEPTIDE CONJUGATES FOR INTRACELLULAR ADMINISTRATION OF STAPLED PEPTIDES

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023115915A Division JP2023134675A (ja) 2017-10-27 2023-07-14 ステープルペプチドの細胞内送達のためのポリペプチド接合体

Publications (3)

Publication Number Publication Date
JP2021501201A JP2021501201A (ja) 2021-01-14
JP2021501201A5 true JP2021501201A5 (enExample) 2021-12-09
JP7780253B2 JP7780253B2 (ja) 2025-12-04

Family

ID=66247031

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020543254A Active JP7780253B2 (ja) 2017-10-27 2018-10-28 ステープルペプチドの細胞内送達のためのポリペプチド接合体
JP2023115915A Pending JP2023134675A (ja) 2017-10-27 2023-07-14 ステープルペプチドの細胞内送達のためのポリペプチド接合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023115915A Pending JP2023134675A (ja) 2017-10-27 2023-07-14 ステープルペプチドの細胞内送達のためのポリペプチド接合体

Country Status (6)

Country Link
US (2) US11510991B2 (enExample)
EP (1) EP3700548A4 (enExample)
JP (2) JP7780253B2 (enExample)
CN (2) CN111447941B (enExample)
CA (1) CA3080617A1 (enExample)
WO (1) WO2019084528A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11339192B2 (en) 2017-10-04 2022-05-24 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
CA3080617A1 (en) 2017-10-27 2019-05-02 Ohio State Innovation Foundation Polypeptide conjugates for intracellular delivery of stapled peptides
US20220315631A1 (en) * 2019-08-30 2022-10-06 Ohio State Innovation Foundation Stapled beta-catenin ligands
CN112245593B (zh) * 2020-10-30 2022-05-13 西南交通大学 具有疏水性侧链的稳定化细胞穿膜肽及制备方法与应用
KR20240031957A (ko) * 2021-06-08 2024-03-08 포그 파마슈티컬스 인코포레이티드 스테이플화된 펩티드 및 이의 방법
EP4448543A1 (en) 2022-01-06 2024-10-23 Oak Crest Institute of Science Subdermal implant for sustained drug delivery

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032235A1 (de) 1998-11-26 2000-06-08 Pentapharm Ag Transportsystemkonjugate
US7033597B2 (en) 2000-10-13 2006-04-25 Université de Lausanne Intracellular delivery of biological effectors
EP1345956A2 (en) 2000-10-13 2003-09-24 University of Lausanne Intracellular delivery of biological effectors by novel transporter peptide sequences
NZ627528A (en) 2012-02-15 2016-05-27 Aileron Therapeutics Inc Peptidomimetic macrocycles
WO2013150338A1 (en) 2012-04-04 2013-10-10 Centre National De La Recherche Scientifique Stapled cell penetrating peptides for intracellular delivery of molecules
JP6272853B2 (ja) * 2012-07-11 2018-01-31 ジェムバックス アンド カエル カンパニー,リミティド 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
EP3142679A4 (en) * 2014-03-25 2017-10-11 University of Utah Research Foundation Peptide inhibitors of bcr-abl oligomerization
EP3126375B1 (en) 2014-04-02 2023-12-13 University of Rochester Macrocyclic peptidomimetics for alpha-helix mimicry
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
PL3149025T3 (pl) 2014-05-21 2019-11-29 Entrada Therapeutics Inc Peptydy penetrujące komórkę i sposoby ich wytwarzania i stosowania
GB2545898B (en) 2015-12-21 2019-10-09 Sutura Therapeutics Ltd Improved drug delivery by conjugating oligonucleotides to stitched/stapled peptides
WO2017147283A1 (en) * 2016-02-23 2017-08-31 Dana-Farber Cancer Institute, Inc. Method for generating cell-penetrating stapled peptides that lack nonspecific membrane-lytic properties for therapeutic targeting
CN110114075B (zh) 2016-11-09 2024-01-12 俄亥俄州国家创新基金会 含有二硫化物的细胞穿透肽及其制备和使用方法
US20190309020A1 (en) 2016-11-22 2019-10-10 Ohio State Innovation Foundation Cell-penetrating peptide sequences
TWI853790B (zh) 2016-11-22 2024-09-01 俄亥俄州立創新基金會 細胞穿透肽序列
CA3080617A1 (en) 2017-10-27 2019-05-02 Ohio State Innovation Foundation Polypeptide conjugates for intracellular delivery of stapled peptides

Similar Documents

Publication Publication Date Title
JP2021501201A5 (enExample)
DE69020143T2 (de) Verfahren zur verwendung und herstellung von peptiden.
DE60208684T2 (de) Verbesserte native chemische ligation mit drei oder mehreren komponenten
DE69333397T2 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DE602004009705T2 (de) Methoden der Verhinderung und Behandlung der Alzheimer'schen Krankheit
DE4434551A1 (de) Peptide aus der Sequenz des hPTH (1-37)
SA518391996B1 (ar) نظائر عامل النمو الجلدي شبيه مجال أ ببدائل حمض دهني
JP2014224121A5 (enExample)
EP2829549A3 (en) Hybrid and tandem expression of neisserial derived proteins
KR870002163A (ko) 펩티드의 제조방법
JPS61502839A (ja) ミモトープを検出または決定する方法
JP2018508492A5 (enExample)
DE602004009710T2 (de) Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
Kitas et al. Fmoc-polyamide solid phase synthesis of an O-phosphotyrosine-containing tridecapeptide
JP2015504893A5 (enExample)
DE896583T1 (de) Neue osp-c abgeleitete peptidefragmente
DE69223250T2 (de) Detektion des immunschwäche-virus aus felis
SMITH et al. Conformational mimicry II. An obligatory cis amide bond in a small linear pep tide
JP2016520529A5 (enExample)
CA1282550C (en) Methods and compositions for preparation of h-arg-x-z-y-tyr-r
DE69114339T2 (de) Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu.
ATE172983T1 (de) Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik
DE69530380T2 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
WO2011008863A4 (en) Stereoisomer peptides and their polymer conjugates for hiv disease
DE3400434A1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern